-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

Benzinga·09/16/2026 12:09:16
语音播报
RBC Capital analyst Luca Issi initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Outperform rating and announces Price Target of $18.